Catalog No.
Product Name
Application
Product Information
Citations
-
Antibiotic
2-Hydroxy-5-iminoazacyclopent-3-ene is a pyrroline antibiotic that targets bacterial cell wall synthesis. This compound exhibits moderate antibacterial activity against both Gram-positive and Gram-negative bacteria, making it a valuable tool for investigating antibiotic resistance mechanisms. Research applications include studying bacterial susceptibility and the development of new antibiotic therapies. -
Antibiotic
Pyralomicin 1b is an antibiotic known for its antibacterial activity. It acts by inhibiting bacterial protein synthesis, making it effective against a range of Gram-positive pathogens. This compound is valuable for research focused on bacterial resistance mechanisms and the development of new antimicrobial agents. -
Antibiotic
44-Homooligomycin A is an antitumor antibiotic that primarily targets fungal pathogens, demonstrating notable activity against species such as Aspergillus, Penicillium, and Fusarium. This compound shows limited efficacy against yeast and bacteria. In preclinical studies, 44-Homooligomycin A exhibits moderate antitumor activity against the Colon 26 cell line in vivo, making it a candidate for further investigation in cancer research and antifungal therapeutics. -
Antibiotic
Pyloricidin B is an antibiotic that specifically targets Helicobacter pylori. It exhibits significant antibacterial activity against this pathogen, making it a valuable tool for research related to gastric infections and related conditions. Pyloricidin B demonstrates selectivity, showing no activity against other bacterial species or yeast, highlighting its potential utility in studying H. pylori-related diseases. -
Antibiotic
4-O-Demethyl-11-deoxydoxorubicin is an anthracycline antibiotic that primarily targets DNA, resulting in the inhibition of topoisomerase II activity. It exhibits significant cytotoxicity against various cancer cell lines, including HeLa cells. This compound is utilized in research focusing on anti-cancer mechanisms and the development of novel therapeutic strategies. -
Antibiotic
Seitomycin is an anthraquinone antibiotic that primarily targets bacterial cells. It exhibits moderate antimicrobial activity against a range of Gram-positive bacteria, including Staphylococcus aureus and Bacillus subtilis, as well as Gram-negative bacteria such as Escherichia coli and Streptomyces chlorophyllus. This compound is relevant for research applications focusing on antibiotic susceptibility, bacterial resistance mechanisms, and the development of new antimicrobial agents. -
Antibiotic
Nebramycin V' is a multi-component aminoglycoside antibiotic that primarily targets bacterial ribosomes, inhibiting protein synthesis. It exhibits broad-spectrum activity against both Gram-positive and Gram-negative bacteria, as well as mycobacteria. This makes it valuable for research applications related to antimicrobial resistance, bacterial infections, and the study of protein synthesis mechanisms. -
Antibiotic
Noboritomycins A is a polyether antibiotic that primarily targets Gram-positive bacteria. It exhibits antimicrobial activity, making it a valuable compound in the study of bacterial infections. Additionally, Noboritomycins A demonstrates weak anti-coccidial effects, which may be of interest in research related to parasitic diseases. -
Antibiotic
4-Hydroxyphlebiarubrone is a quinone antibiotic that exhibits activity against certain bacterial strains. It demonstrates weak resistance to Gram-negative bacteria, making it of interest in studies related to antibiotic resistance mechanisms. Additionally, its cytotoxic properties warrant further investigation in cellular biology and cancer research applications. -
Antibiotic
Armentomycin is a non-protein amino acid with potent antibiotic properties, primarily targeting Gram-negative bacteria. Its mechanism of action involves inhibition of bacterial growth, making it a valuable reagent for research focused on antibiotic efficacy and resistance mechanisms. Armentomycin serves as a critical tool for studies investigating microbial infections and developing novel antimicrobial strategies. -
Antibiotic
Parvodicin C3 is a glycopeptide antibiotic that exerts its antimicrobial activity by inhibiting bacterial cell wall synthesis. It demonstrates potent activity against various gram-positive pathogens, including Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus, and Enterococcus faecalis. This compound is valuable for research applications focused on bacterial resistance mechanisms and the development of new antibacterial agents. -
Antitumor Antibiotic
4-Hydroxybaumycinol A1 is an anthracycline antibiotic that exerts its primary mechanism through DNA intercalation, leading to the inhibition of topoisomerase II. This compound demonstrates significant antitumor activity, making it a valuable reagent for cancer research. Its potent effects on tumor cell proliferation position it as a useful tool in studies aimed at understanding and developing new cancer therapies. -
Antibiotic
Antibacterial agent 266 is an antibiotic that targets bacterial integrity, effectively inhibiting plant pathogens. It demonstrates notable activity with EC50 values of 24.1 μg/mL against Xanthomonas oryzae pv oryzae and 39.0 μg/mL against Xanthomonas axonopodis pv citri. This reagent is valuable for research in plant pathology and the development of agricultural antimicrobial agents. -
Antibiotic
Maridomycin II is a macrolide antibiotic that targets bacterial protein synthesis. It exhibits potent activity against Gram-positive bacteria and mycoplasma, making it a valuable tool for studying bacterial infections. Additionally, Maridomycin II has demonstrated protective effects in murine models of Gram-positive bacterial infections, highlighting its potential utility in infectious disease research. -
Antibiotic
Milbemycin α14 is an antibiotic that exerts its effects by effectively targeting and eliminating nematodes and mites. This compound is commonly used in research applications focusing on parasitic infections and pest control, providing a valuable tool for biologists studying the mechanisms of action of antiparasitic agents. -
Antibiotic
Fluvirucin A2 is an antibiotic specifically targeting the influenza A virus. It demonstrates potent antiviral activity, disrupting viral replication and reducing infection severity. This compound is valuable for research applications investigating antiviral strategies and the mechanisms of influenza pathogenesis. -
Antibiotic
Halymecin A is an antibiotic derived from marine microbes, primarily targeting bacterial and fungal pathogens. Although it exhibits only weak antibacterial and antifungal activity, it serves as a valuable tool for studies in microbial interactions and the exploration of novel antibacterial compounds. This compound's unique origin and modest bioactivity make it relevant for research in natural product chemistry and antibiotic development. -
Antitumor Antibiotic
Atramycin A is an isotetracenone-based antitumor antibiotic that exhibits potent cytotoxic activity against various cancer cell lines. Its mechanism involves DNA intercalation and the inhibition of topoisomerase II, leading to disruptions in DNA replication and cellular proliferation. Atramycin A is valuable for research applications focused on cancer biology and the development of new antitumor therapies. -
Antibiotic
Cystothiazole B is a bithiazole-type antibiotic that exhibits antimicrobial activity by inhibiting bacterial protein synthesis. It is primarily extracted from the organism Cystobacter fuscus. This compound is utilized in research applications focused on antibacterial mechanisms and the identification of novel antibiotics. -
Antibiotic
Sakyomicin A is an antibiotic derived from the Actinomycete strain M-53, primarily targeting Gram-positive bacteria. This compound demonstrates significant antibacterial activity, making it valuable for research applications focused on microbial resistance and antibiotic efficacy. Its unique mechanism of action facilitates the exploration of new therapeutic options against Gram-positive infections. -
Antitumor Antibiotic
6-Deoxyilludin M is an antitumor antibiotic that exhibits significant antileukemic activity. This compound can be isolated from the culture broth of the Basidiomycota species, Pleurotus japonicus. It serves as a valuable tool for cancer research, particularly in studies aimed at understanding leukemic processes and developing novel therapeutic strategies. -
Antitumor Antibiotic
Feudomycin A is an antitumor antibiotic that inhibits cancer cell proliferation through its unique cyclic structure. Its biological activity includes the induction of apoptosis in various tumor cell lines, thereby demonstrating potential in cancer research and therapeutic applications. Investigations into its mechanistic pathways can facilitate the development of novel anticancer strategies. -
Antibiotic
Epithienamycin A is a carbapenem antibiotic that exerts its action by inhibiting bacterial cell wall synthesis. It demonstrates significant antibacterial activity against both Gram-positive and Gram-negative bacteria, making it a valuable compound for research in antibiotic efficacy and resistance studies. This reagent is useful for evaluating the mechanisms of bacterial susceptibility and potential therapeutic applications in infectious disease management. -
Antibiotic
Biphenomycin A is a cyclic peptide antibiotic derived from Streptomyces griseorubiginosus 43708. It exhibits significant antibacterial activity and is relevant for research in the field of anti-infection. Its unique structure and mechanism offer potential insights into antibiotic development and resistance studies. -
Cephalosporin Antibiotic
CS 461 is a cephalosporin antibiotic that exhibits potent antibacterial activity against both Gram-positive and Gram-negative bacteria, including certain β-lactamase producing strains. This compound is valuable for research focused on infections, providing a well-balanced approach to tackling diverse bacterial pathogens. Its utility in understanding antibacterial mechanisms makes it a significant reagent in the study of antibiotic resistance and infection treatment strategies. -
Antibiotic
Gentamicin C1 is an aminoglycoside antibiotic that primarily targets bacterial ribosomes to inhibit protein synthesis. It exhibits broad-spectrum antimicrobial activity effective against a variety of Gram-negative and some Gram-positive bacteria. This compound is widely used in research and clinical settings for the treatment of serious infections and for studying antibiotic resistance mechanisms. -
Antibiotic
Arylomycin A5 is a lipohexapeptide antibiotic that targets Gram-positive bacteria through inhibition of bacterial protein synthesis. It demonstrates significant antibacterial activity by interfering with the function of ribosomal RNA, making it a valuable tool in the study of antibiotic resistance and bacterial infections. Arylomycin A5 is suitable for research applications aimed at elucidating the mechanisms of action of antibiotics and developing new therapeutic strategies. -
Antibiotic
(1S,2R,7S)-Sitafloxacin is an antibiotic with potent topoisomerase inhibition targeting DNA gyrase and topoisomerase IV in bacteria. It exhibits significant antibacterial activity, with an IC50 of 0.18 μg/mL against Escherichia coli DNA gyrase and effective action against Staphylococcus aureus. This compound is valuable in the study of various bacterial infections and provides insights into antibiotic resistance mechanisms and therapeutic approaches. -
Antibiotic
Napyradiomycin C1 is an antibiotic that exhibits potent activity against Gram-positive bacteria and mycobacterial strains. It demonstrates minimal efficacy against Gram-negative bacteria and fungi. The compound shows an IC50 of 9.2 µg/mL in leukemia L-1210 cells, indicating its potential application in cancer research and the development of novel therapeutic strategies against specific bacterial infections. -
Antibiotic
Auramycin A is an anthracycline antibiotic targeting Gram-positive bacteria, demonstrating significant antibacterial activity. In addition to its antimicrobial properties, Auramycin A exhibits notable antitumor effects against P388 and L1210 leukemia cell lines in murine models, making it a valuable reagent for research in both infectious diseases and cancer therapies. -
Antibiotic
Pristinamycin IB is an ester peptide antibiotic primarily targeting Gram-positive bacteria. Its mechanism involves inhibiting protein synthesis, leading to antimicrobial activity. Pristinamycin IB is used in research applications aimed at understanding bacterial resistance and testing new therapeutic approaches against resistant strains of Gram-positive pathogens. -
Antibiotic
Haloquinone is a quinone antibiotic that demonstrates potent antibacterial activity against Halobacteria, as well as exhibiting effects against Gram-positive bacteria and mycoplasma. This compound is valuable in researching bacterial resistance mechanisms and the efficacy of novel antibiotic therapies. Its broad-spectrum activity makes it a useful tool for microbiological studies and drug development in the field of infectious diseases. -
Antitumor Antibiotic
Baumycin C1 is an antitumor antibiotic that exerts its biological activity through the inhibition of DNA synthesis. This compound demonstrates potent cytotoxic effects against various cancer cell lines, making it a valuable tool for cancer research. Its mechanism of action and efficacy position Baumycin C1 as a potential candidate for studies investigating novel antitumor therapies. -
Antimicrobial Antibiotic
Sperabillin C is an antimicrobial antibiotic that exhibits potent activity against both Gram-negative and Gram-positive bacteria, including resistant strains such as Pseudomonas aeruginosa and Staphylococcus aureus. Its ability to target a wide spectrum of bacterial pathogens makes it a valuable reagent for research applications in antibiotic resistance studies and the development of new antimicrobial therapies. -
Antibiotic
Pyralomicin 2a is an antibiotic that demonstrates significant antibacterial activity by targeting bacterial cell wall synthesis. It is primarily utilized in research to investigate its effectiveness against various bacterial strains and to explore its potential therapeutic applications in treating bacterial infections. This compound provides a valuable tool for studying antibiotic resistance and the mechanisms of action of antibacterial agents. -
Antibiotic
Desertomycin B is an antibiotic derived from the guanidino form of a fermentation product of Streptomyces flavofungi. This compound exhibits potent antibacterial activity, demonstrating effectiveness against a range of gram-positive bacteria. Desertomycin B serves as a valuable tool in microbiological research and the study of antibiotic resistance mechanisms. -
Antibiotic
Celesticetin B is an antibiotic that primarily targets Gram-positive bacteria. It exhibits significant antibacterial activity, making it a valuable tool in the study of bacterial infections and resistance mechanisms. This compound is particularly useful for research focusing on the development of new therapeutic strategies against Gram-positive pathogens. -
Antibiotic
Hongoquercin A is a sesquiterpene antibiotic that exhibits moderate activity against Gram-positive bacteria, with a minimum inhibitory concentration (MIC) ranging from 4 to 8 μg/mL. This compound is valuable for research applications focused on antibiotic development and bacterial susceptibility studies. Its unique structure and mechanism of action make it a significant candidate for further exploration in microbial resistance and therapeutic interventions. -
Antibiotic
Lincosamine is a lincosamide antibiotic that inhibits bacterial growth through interference with protein synthesis. Produced by Streptomyces lincolnensis, Lincosamine demonstrates efficacy against various bacterial infections, particularly Klebsiella pneumoniae. Its activity has been benchmarked against other antimicrobial agents, highlighting its relevance in the study of bacterial resistance and the development of new therapeutic strategies. -
Antibiotic
Actiketal is a glutarimide antibiotic that primarily targets bacterial RNA synthesis. It demonstrates potent inhibition of [3H]thymidine incorporation in EGF-stimulated Balb/MK cells, indicating its potential effects on cell proliferation and differentiation. This compound is useful in research applications focused on understanding bacterial resistance mechanisms and exploring the role of antibiotics in cellular responses. -
Antitumor Antibiotic
Cypemycin is a linaridin antibiotic that exhibits antitumor activity by inhibiting cancer cell proliferation. It demonstrates significant cytotoxicity against P388 leukemia cells, with an IC50 of 1.3 μg/mL. Additionally, Cypemycin is effective against various human tumor cell lines, including HeLa S3, HHCC-1, HCCS-M, and Slex, with IC50 values greater than 25 μg/mL. This compound serves as a valuable tool for researching cancer therapeutics and understanding mechanisms of tumor cell resistance. -
Antibiotic
Fluvirucin A1 is an antibiotic that specifically targets the influenza A virus. It exhibits potent antiviral activity, making it a valuable tool for researchers studying influenza infections and potential therapeutic interventions. Fluvirucin A1 can be utilized in preclinical studies to explore mechanisms of viral resistance and efficacy of antiviral compounds. -
Antibiotic
Monamycin G3 is an ester peptide antibiotic that primarily targets Gram-positive bacteria. It exhibits potent antibacterial activity, making it a valuable reagent for investigating bacterial resistance mechanisms and evaluating the efficacy of antimicrobial agents in research settings. Its unique structure and mode of action make it an important tool for studies involving infection models and antibiotic development. -
Antibiotic
PF1140 is a fungal-derived antibiotic that exhibits potent antimicrobial activity against various infectious agents. It is primarily used in the study of infectious diseases, allowing researchers to investigate its efficacy and mechanisms of action. PF1140's unique properties make it a valuable tool for understanding antibiotic resistance and developing new therapeutic strategies. -
Antibiotic
Oxypyrrolnitrin is a nitrogen-containing heterocyclic antibiotic that exhibits broad-spectrum antibacterial and antifungal activity. It demonstrates efficacy against Gram-positive and Gram-negative bacteria, as well as mycobacteria and various fungi. This compound is valuable for research applications focused on combating bacterial resistance and studying fungal infections. -
Antibiotic
3-O-Demethylmonensin A is a polyether antibiotic that functions by disrupting ion transport across cell membranes, primarily targeting bacterial cells. This compound exhibits notable antibacterial activity and has been used in research to study antibiotic mechanisms and resistance. Its specific effects make it valuable for investigating microbial interactions and cellular processes in various biological systems. -
Antibiotic
Himalomycin A is an anthraquinone antibiotic that exhibits potent antibacterial activity against Staphylococcus aureus, Escherichia coli, and Streptomyces vuridochromogenes. Its mechanism of action involves interference with bacterial DNA synthesis and function, making it a valuable tool for studying antimicrobial resistance mechanisms and assessing bacterial susceptibility in research applications. This compound serves as a useful reagent for investigations in microbiology and antibiotic development. -
Antibiotic
Desmethyl ofloxacin hydrochloride is a primary metabolite of the fluoroquinolone antibiotic ofloxacin, targeting bacterial DNA gyrase and topoisomerase IV. This compound exhibits significant antibacterial activity against a variety of Gram-positive and Gram-negative bacteria. It is utilized in research to investigate mechanisms of antibiotic resistance and to explore the pharmacokinetics of fluoroquinolone antibiotics. -
Antibiotic
Oxamicetin is a nucleoside antibiotic targeting bacterial cell mechanisms. It exhibits potent anti-bacterial activity, particularly against mycobacteria, making it a valuable reagent for research focused on bacterial infections and resistance. Its unique properties facilitate studies in microbiology and contribute to the development of new therapeutic strategies. -
Antibiotic
Lincomycin B is an antibiotic derived from the bacterium Streptomyces lincolnensis. It exhibits potent antibacterial activity against a variety of Gram-positive bacteria, making it valuable for research in microbial pathogenesis and antibiotic resistance. Lincomycin B is often utilized in studies exploring microbial inhibition and the development of novel therapeutics.
